Dr Sreekanth Gopinathan Pillai

Associate Professor

沙巴体育 Institute of Virology

CURRENT ACADEMIC ROLE & RESPONSIBILITIES

    • Teaching post-graduate and doctoral students at MIV for coursework
    • Guiding Ph.D and MSc.? students at MIV for their research projects
    • Involved in various research committees in India
    • 沙巴体育 Projects: Ongoing - 3? ? ? ? ? ? ? ? ?

SUBJECTS CURRENTLY TEACHING

Subject Semester / Year
Cell Biology 1st semester
Immunology of Viral Diseases 1st semester

ACADEMIC QUALIFICATIONS

Degree Specialisation Institute Year of passing
PhD Biochemistry (Medical Program) Mahidol University, Thailand (Faculty of Medicine Siriraj Hospital) 2013

Experience

Institution / Organisation Designation Role Tenure
沙巴体育 Institute of Virology Associate Professor 2025-Present
沙巴体育 Institute of Virology Assistant professor 2024-2025
Department of Applied Biology, CSIR-Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad, India Project Scientist - III 2021-2024
ICGEB-Emory Vaccine Centre, DBT-沙巴体育 Centre for Genetic Engineering and Biotechnology (DBT-ICGEB), New Delhi, India 沙巴体育 Scientist 2019-2021
Faculty of Medicine Siriraj Hospital, Mahidol University - Thailand 沙巴体育 Associate 2013-2019
Amrita Institute of Medical Sciences & 沙巴体育 Centre - Kochi, India 沙巴体育 Coordinator 2008-2010
Amrita Institute of Medical Sciences & 沙巴体育 Centre - Kochi, India Project Fellow 2007-2008

AREAS OF INTEREST, EXPERTISE AND RESEARCH

Area of Interest

? Viral Infections of National Importance: Dengue, KFDV, Nipah, and Rare Viral Infections ? Translational approaches to combat emerging and re-emerging viral infections ? Development of Reverse Genomics Approaches to Antiviral Discoveries ? Antiviral Testing (Novel compounds, inhibitors, drug repurposing, natural products, etc.) ? Developing novel delivery systems for antivirals (in vitro and in vivo models) ? Randomized-controlled trials to viral infections (Vaccines, Adjuvants, and Antiviral agents) ? Molecular signaling towards the host-pathogen interface and its impact on virus life stages ? Identifying novel molecular markers for viral infections (pre-clinical and clinical studies)

Area of Expertise

Molecular pathogenesis of viral infections, in vitro and in vivo models of dengue virus infection, antiviral development and clinical trials to viral infection

Area of 沙巴体育

Understanding the molecular pathogenesis and drug development to combat viral infections of national importance (Dengue, KFDV, Nipah, Zika, and Rare Viruses)

Professional Affiliations & Contributions

Accomplishments:

? Member of Royal Society of Biology (MRSB), United Kingdom (01/10/2019 onwards)

? Associate Editor, Frontiers in Immunology

? Review Editor, Frontiers in Immunology??

? Associate Editor, Frontiers in Cellular and Infection Microbiology?

? Member, Institutional Ethics Committee (IEC), Department of Homoeopathy, Govt. of Kerala, Thiruvananthapuram.

? Co-chair, Scientific Advisory Board (SAB-DHK), Department of Homoeopathy, Thiruvananthapuram, Govt. of Kerala.

? SCIRE Young Scientist Award (2019), SCIRE 沙巴体育 Forum, Cochin, Kerala India; 06 Nov 2019.

? Travel Award to attend 35th 沙巴体育 Conference on Antiviral 沙巴体育 (ICAR-2022), Seattle, WA, USA, 沙巴体育 Society for Antiviral 沙巴体育 (ISAR), USA.

? Travel Award to attend 33rd 沙巴体育 Conference on Antiviral 沙巴体育 (ICAR-2020), Seattle, WA, USA, 沙巴体育 Society for Antiviral 沙巴体育 (ISAR), USA.

? Travel Award to attend 17th 沙巴体育 Congress of Virology (IUMS-2017), Singapore; Singapore Society for Microbiology and Biotechnology (SSMB), Singapore.

? Best Thesis Publication Award in Health Sciences, Year 2013; Faculty of Graduate Studies, Mahidol University, Thailand.

? Ph.D. Scholarship - The Graduate Scholarship for 沙巴体育 Students (Full Scholarship); Faculty of Medicine Siriraj Hospital (Mahidol University), Bangkok, Thailand.

? Certificate of Appreciation - Successful completion of Phase-II clinical study in Psoriasis; Biocon India, Bangalore, Karnataka, India.

Certifications:?

? Collaborative Institutional Training Initiative (CITI Program), Mahidol University, Thailand.

? Biomedical Responsible Conduct of 沙巴体育

? Working with Mice in 沙巴体育 Settings

? Working with Rats in 沙巴体育 Settings

? Human Subjects 沙巴体育 (Biomedical 沙巴体育ers)

? Good Clinical Practice (沙巴体育er Biological)

? Institutional Official: Animal Care and Use

? Working with the IACUC (Lab Animal 沙巴体育)

? Information Privacy Security (IPS) - 沙巴体育ers

? Post-Approval Monitoring (Lab Animal 沙巴体育)

? Biosafety: Risk Assessment and SOP Development, Mahidol University, Thailand.

? Laboratory Animal Care - National Laboratory Animal Centre (NLAC), Mahidol University, Thailand.

? Good Laboratory Practice (GLP) and Biohazards in Laboratory Practices, Mahidol University, Thailand.

? ICH-GCP, Amrita Vishwa Vidyapeetham University, Kochi, Kerala, India.

? GCP and NDCT Rules, Issues in 沙巴体育 with Traditional Systems of Medicine, ICMR National Ethics Guidelines and Roles & Responsibilities of EC, Forum for Ethics Review Committee in India (FERCI), India.?

Memberships:

? 沙巴体育 Society for Antiviral 沙巴体育 (ISAR)

? Indian Virological Society (IVS) – Life Member

? Indian Immunology Society (IIS) - Life-Member

? Microbiology Society, UK (Affiliate Member)

? The American Society of Microbiology (ASM)

? Society of Biological Chemists, India (SBC, India)

For full publication list click here

1. Ms. Susmitha V (2025) - Title: Correlation of Interleukin-36γ Expression with Dengue Severity Identifies It as a Potential Therapeutic Target